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Abstract 
Glycogen, a complex branched polymer of glucose (average chain length ~10 monomer 
units), is the blood-sugar reservoir in humans and other animals. Certain aspects of its 
molecular structure relevant to its biological functions are currently unamenable to 
experimental exploration. Knowledge of these is needed to develop future models for 
quantitative data-fitting to obtain mechanistic understanding of the biosynthetic processes 
that give rise to glycogen structure. Monte Carlo simulations of the biosynthesis of this 
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structure with realistic macromolecular parameters reveal how chain growth and stoppage 
(the latter assumed to be through both the action of glycogen branching enzyme and other 
degradative enzymes, and by hindrance) control structural features. The simulated chain-
length, pair-distance and radial density distributions agree semi-quantitatively with the 
limited available data. The simulations indicate that a steady state in molecular structure and 
size is rapidly obtained, that molecular density reaches a maximum near the center of the 
particle (not at the periphery, as is the case with dendrimers), and that particle size is 
controlled by both enzyme activity and hindrance. This knowledge will aid in the 
understanding of diabetes (loss of blood-sugar control), which has been found to involve 
subtle differences in glycogen molecular structure. 
1. Introduction 
Glycogen is a complex hyperbranched glucose polymer, with essentially random branching, 
where individual chains (branches) are formed by α-D-glucosyl (anhydroglucose) units 
through (1→4) linkages; these chains are joined by (1→6) branch points (there is also a small 
but significant amount of bound protein [1]). The average chain length is ~10 monomer units. 
An important function of this molecule is to regulate blood-sugar levels in mammals and 
other organisms. Glycogen has multiple structural levels: that of the individual chains 
(branches), that of the whole branched molecules (which when isolated are termed β particles) 
and lastly tightly bound agglomerations of β particles, termed α particles [2]. Muscles (where 
there is a need for rapid energy release, e.g. during exertion) have more small particles, which 
degrade relatively quickly to glucose (to be more precise to glucose-6-phosphate, as muscle 
cells lack glucose-6-phosphatase) [3]. The largest single glycogen reservoir in the body is the 
liver, where (depending on the time after a meal [4]), glycogen can be found as the much 
larger α particles, which provide the slow and controlled glucose release needed, for example, 
during overnight fasting in diurnal animals. 
It has been found that the molecular structure of the α particles of liver glycogen are more 
fragile in diabetic mice as compared to healthy mice [4-6]. Specifically, in the presence of 
dimethyl sulfoxide (DMSO, which disrupts H bonds), diabetic α particles fragment into 
smaller β particles in vitro, and the rate of enzymatic degradation to glucose of the latter is 
faster than of intact α particles [3]. This could well be related to the cause, the effect, or both, 
of the uncontrolled glucose regulation which is a characteristic of diabetes. 
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Understanding the differences in molecular structure of this complex branched polymer 
between different samples is thus of significance for human health, given the rising incidence 
of diabetes world-wide. There are also other, much rarer, pathologies such as the different 
types of glycogen storage diseases [7] and Lafora disease [8] to which this study is relevant. 
Appropriate structural information includes the size distribution of the whole branched 
molecule, and of individual branches (chains – the chain-length distribution, CLD) following 
enzymatic debranching; accurate data for both of these are readily obtained experimentally. 
The number CLD is denoted Nde because it is found experimentally as the number of chains 
with a given DP following enzymatic debranching. Information pertaining to the molecular 
density of the whole (branched) molecule can also be obtained after size separation into 
relatively size-monodisperse samples, e.g. by SAXS, and by size-exclusion chromatography 
with dual detection. Quantitative interpretation of these data could lead to new understanding 
of the mechanisms of in vivo synthesis and degradation, and of the relations between 
structural features and properties such as degradation rate.  
Such interpretation requires appropriate theory. A quantitative model for the CLD has been 
developed [9, 10] for a molecule with many similarities to glycogen, namely amylopectin 
(one of the two glucose polymers in starch, which like glycogen is highly branched with 
(1⟶4)-α linear links and (1⟶6)-α branch points). Application of this model has indeed led 
to many insights. Given certain simplifications (such as the independence of enzyme 
activities on the degree of polymerization (DP) of the growing chain), relations for the CLD 
can be written down in terms of an infinite set of coupled first-order differential equations in 
terms of a single independent variable, the DP; this is completely analogous to the 
corresponding relations for the molecular weight distribution of unbranched polymers in free-
radical polymerization. The resulting equations are complicated but can be readily solved in a 
form that is relatively easy to fit to data [9, 10]. 
The main enzymes involved in the biosynthesis of both starch and glycogen (starch/glycogen 
synthases, branching enzymes and debranching enzymes) have many similarities. However, 
there are some important biosynthetic differences. The first is that the main starch production 
and storage organ in a plant, the endosperm, is a very different environment from that in the 
liver of an animal. The second is the existence of an additional mechanism in glycogen 
biosynthesis: chain stoppage by hindrance [11-13] as the molecule grows (as also occurs, for 
example, with synthetic dendrimers [14]); this is not significant in starch because the space 
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between branch points is controlled by one of the starch debranching enzymes. A third 
difference is that although synthetic “glycogen” can be grown in vitro [15], these molecules 
do not arise from the complex regulatory environment in which animal glycogen is 
synthesized [16, 17], and thus the insight into mechanisms for the in vivo biosynthesis of 
starch by using in vitro laboratory models may be less applicable to glycogen than they have 
been to amylopectin. A fourth problem is that sensitive in vivo experimental data on glycogen 
molecular structure are limited: for example, while good data on structural features such as 
pair distributions using SAXS have been obtained [18], and good CLD data are available 
(e.g., work by the present group [11]), these data were not obtained for the same system, and 
moreover were for systems where there was inadequate size separation of the glycogen 
molecules in the samples. 
These complexities result in the need for some guidance as to how these mechanisms can be 
put into the development of a model for glycogen CLD that will be analogous to (but 
significantly more complex than [17]) that previously developed [9, 10] for amylopectin. The 
objective of this paper is to perform a Monte-Carlo simulation of the growth of a glycogen β 
particle; we do not consider binding of β particles into composite α particles, which involves 
steps additional to the growth of individual β particles [19]. This will build upon, but go 
beyond earlier simulation work. Pioneering simulations were carried out by Melendez and 
colleagues [13, 20-22], but these had a number of restrictions (necessitated in part by the 
limitations of computational power when this work was done). These included highly 
simplified inclusion of the enzyme kinetics, of which the understanding has significantly 
advanced in the intervening decades, and limited account of chain self-avoidance. A reverse 
Monte-Carlo simulation approach [23] had limitations in the problem of self-avoidance, and 
was such that the enzyme kinetics were assumed in the model by using actual CLDs (this has 
led to a useful model for randomly-branched polymers and for interpreting some types of 
experimental data [24-26]).These simulations did not take into account effects such as 
restricted access to an enzyme in a particular region due to the enzyme being unable to fit 
into the available space. The present paper goes beyond previous simulations by 
implementing a Monte-Carlo simulation of the growth of a glycogen molecule, using current 
knowledge of the dependences of the biosynthetic enzymes on the DP of the growing chain 
[10], and realistic inclusion of self-avoidance (which inherently simulates the effects of 
hindrance of both polymer and enzymes). We carry out semi-quantitative comparisons of the 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Page 5 
simulation results with extant, albeit limited, available data to see if the model is likely to be 
a reasonable representation of the actual molecule. 
The types of questions which might be answered by these simulations are: whether the CLD 
attains a steady state in time during growth; how the conformation of chains within the 
branched molecule varies with total chain DP and the position of individual monomer units 
on that chain; the dependence of molecular density and of the CLDs on enzyme activities and 
distance from the center of the particle; and what mechanism stops β particles from growing 
beyond the observed size range. It is noted that the stoppage of growth of a dendritic polymer 
is by hindrance [14], and it has been suggested [21] (and often assumed) that the same is true 
of glycogen β particles. The knowledge from the simulation data could be used in subsequent 
work to develop heuristic models, as well as to understand experimental data. 
2. Simulation Method 
The basic method is a Monte-Carlo approach to the growth of a whole molecule from a single 
monomer unit(the action of the starter protein, glycogenin [27], is implicitly included in this 
step), taking account of the kinetics of addition by propagation (the action of glycogen 
synthase, GS) and of formation of a branch (by glycogen branching enzyme, GBE). 
Mathematical evidence suggests [17] that the action of various degradative enzymes such as 
glycogen phosphorylase (GP), glycogen debranching enzyme (GDBE) and α-glucosidase 
(GAA) [16] must be considered in biosynthetic models to obtain structures consistent with 
experimental glycogen CLDs. GP can remove terminal glucose monomers from the non-
reducing ends of chains until it reaches a point four residues away from a(1→6) branching 
linkage. GDBE removes chains with a DP of 4, by first removing the three terminal units 
together and placing these on the terminal end of a new branch, before removing the final 
unit from the original branch location. The function of GAA is similarly to remove the 
terminal unit by hydrolysis of (1→4) linkages but without the same stopping condition four 
residues away from a branch point that restricts the action of GP (while GAA can also 
hydrolyze (1→6) linkages at a low rate, this function is neglected in this method). Moreover, 
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GAA is modeled as being unable to act on chains of DP 1 in this treatment, as action on a 
chain of DP 1 would represent hydrolysis of a (1→6) linkage. 
The action of GBE is rather complicated. It seems to have the same mode of action as starch 
branching enzyme (SBE) [28] (which is reasonable given the similarities between starch and 
glycogen biosynthetic enzymes [29]).These branching enzymes act only on chains greater 
than some minimum DP (e.g. Guan et al. [30]), denoted Xmin; further, in planta studies 
[31]indicate that the chain remaining after this action of branching enzyme must have at least 
a minimum number of monomer units, denoted X0. In vitro studies suggest the values for 
each of these parameters are likely 6 or 7 for GBE [28]. In the present simulations, Xmin is set 
as 7 and X0 as 6; only chains where DP ≥ X0+Xmin can be acted on by GBE [28]. 
2.1. Self-avoiding walk (SAW) model 
To take proper account of hindrance in the simulations, it is essential to make the chains self-
avoiding. Rather than implementing a general treatment of self-avoidance, we use a lattice 
model (which enormously reduces the required computational resources, compared to using a 
spatial continuum), with the polymer growth simulated using a self-avoiding walk (SAW). 
Variants on this method have been used extensively. For example, Tries et al. [32] have 
mapped a polymer system in the melt onto a cubic lattice, and found a good quantitative 
match to experiment. Hsu et al. [33] reported a Monte-Carlo simulation for bottle-brush 
polymers on a cubic lattice and found a good comparison of the predicted structure factors 
with experiment. Ordemann et al. [34] studied the scaling properties of linear polymers with 
fractal structures modeled by the SAW on a Sierpinski lattice, with results consistent with 
renormalization group theory. 
In this method, each monomer unit is represented by a grid point in 3D space which can only 
have values 0 (empty) or 1 (occupied). The formulation adopted here, illustrated in Fig.1, is 
such that adding a monomer unit can be done in 26 possible different growing directions, by 
using a cubic space grid (as used in some other lattice simulations [33, 35]). These 26 
possible directions allow the chain to grow in any direction, not only outward as in the first 
good simulations in this field [13, 20-22]. 
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Fig. 1 The 26 different directions of growth of a monomer unit. The arrows indicate the 
directions (the length of the arrows is not meaningful) in which a new monomer unit can add. 
The growth of a glycogen chain is taken to be a self-avoiding random walk (SAW): adding 
one monomer at the end of a chain by randomly selecting one direction from the 26. If there 
already is another unit in the grid point, the growth of the chain stops. 
2.2. Enzyme activities 
The rate parameters controlling glycogen structure are the activities of GS, GBE, GP, GDBE 
and GAA (while GAA is only present during lysosomal degradation, its effect on observed 
CLDs is for simplicity considered together with the effects of the other biosynthetic enzymes 
in this treatment). In the present work, the values of each are taken as 30, 1, 3×10
–5
, 1.5×10
–4
 
and 3×10
–5
, respectively (the units are arbitrary, and it is only the relative values that are 
important for the purposes of this study). Those of GS and GBE are the lower range of values 
from model fitting to in vivo experimental data [11] for various mammals of Nde(X) over the 
range DP 7 – 14, assuming that glycogenesis is dominated by GS and GBE. The values of 
GP, GDBE and GAA activities were found by trial-and-error to fit data. 
2.3. Monte-Carlo (MC) procedure 
The specific MC simulation steps are as follows. 
1. Randomly select an enzyme event according to the values of activity ratios for the 
various enzymes. 
2. The influence of the size of the propagation enzyme, GS, is taken into account as 
follows. Because the size of GS is ~ 7 nm from X-ray data [36] and the size of a 
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monomer unit is ~1.5 nm (also from diffraction data [37])the radius of GS is taken as 
5 times that of the monomer (our simulations show that the final results are not very 
sensitive to this value). The size of the monomer unit is that between grid points. The 
movement is rejected if there are more than a certain number (N) of occupied grid 
points. This is taken as a spherical region with 5 grid points as its radius, where the 
spherical region is defined as a sphere which is composed of many grid points in a 
lattice, the edge of which is made from grids in a lattice, as illustrated in the 
Supporting Information. Thus the larger the number of grids and the denser the grid 
density, the closer the “spherical” region is to being truly spherical. Five grid points 
are set up as the radius of the spherical region around the chosen grid point for the 
next propagation step. For propagation, the value of N is taken as 33. This value was 
chosen by trial-and-error by comparing simulation data with the limited experimental 
data currently available. 
3. If a propagation event is chosen, randomly select a chain and add a monomer unit at 
the end of this chain. However, if any one of two following situations happens, the 
propagation step is rejected: (i) the selected neighboring grid point is occupied; (ii) 
there is not enough space for the GS to touch the target. After the propagation event is 
finished, jump back to step 1. 
4. If a branching event is chosen, there are three procedures to be undertaken. Firstly, 
randomly select a chain to be branched; the DP of this chain must be X0+ Xmin; 
otherwise, jump back to step1. Secondly, randomly select a snipping point with a DP 
≥ X0 with snipped component having DP ≥ Xmin. The size of GBE (equivalent to that 
of GS in step 2) is taken as N = 25, again this value being chosen by trial-and-error 
comparison with extant data. If the space is not enough for GBE, reject this step and 
jump back to step 1. Thirdly, again randomly select a chain (including the branch that 
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was snipped) as well as a monomer unit on it to which the snipped branch will be 
attached. There is probably a preference to attach to nearby chains, but this 
enhancement is left for future work. However, in this step, if any one of two 
following situations happens, the snipped branch will be deleted from the system and 
the program will jump back to step 1 (although it is possible that this chain might be 
attached somewhere else, a refinement which is left to the next version of the present 
model). (i) There is another branch 4 or fewer units away from the selected monomer 
unit, this value being suggested as about the minimum space needed for BE to operate 
[13, 20, 21]; (ii) there is not enough space fora whole snipped branch (tested by 
seeing if there are enough contiguous vacancies when a region is randomly chosen to 
locate the newly-snipped portion). 
5. If a chain-shortening event for GP is chosen, firstly, randomly select a chain of DP ≥ 
5. The size of GP (equivalent to that of GS in step 2) is taken as N = 20, again this 
value being chosen by trial-and-error comparison with extant data. If the space is 
insufficient for GP, reject this debranching step and jump back to step 1. Secondly, 
remove one terminal subunit of this selected chain. 
6.  If debranching event for GDBE is chosen, firstly, randomly select a chain with DP 4. 
The size of GDBE (equivalent to that of GS in step 2) is taken as N = 33, again this 
value being chosen by trial-and-error comparison with extant data. If the space is 
insufficient for GDBE, reject the debranching step and jump back to step 1. If the 
debranching step is successful, remove the 4 terminal subunits of this selected chain; 
the3 terminal subunits are added to the end of another randomly chosen chain (similar 
to branching enzyme, but the snipped part is added to the end of the chain instead of 
becoming a new branch) while the remaining single residue is discarded. As in step 4, 
the preference for nearby chains is not considered at this stage. 
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7. If a degradation event for GAA is chosen, firstly, randomly select a chain with DP > 1. 
The size of GAA (equivalent to that of GS in step 2) is taken as N = 20, again chosen 
by trial-and-error comparison with extant data. If the space is insufficient for GAA, 
reject the debranching step and jump back to step 1. Secondly, remove 1 terminal 
subunit of this selected chain.  
It is noted that this methodology takes explicit account of chain stoppage by hindrance. 
3. Results and Discussion 
Some models for glycogen structure [21, 22, 37, 38] suggest that the growth of glycogen will 
stop when the density of monomer units reaches a maximum caused by crowding; however, 
other simulations [26] indicate the reverse: that the maximum density is at the center of the 
particle. One of the aims of the present paper is to resolve these contradictory indications. 
Some researchers [13, 20-22, 39-41] used a hierarchical structure to describe glycogen. 
Specifically, those models indicate that a full-size glycogen molecule would consist of 12 
tiers, for a total of about 55000 glucose residues, and a diameter of about 44 nm. On the other 
hand, Shearer and Graham [42] performed careful analysis of the sizes of glycogen particles 
present in skeletal muscle by transmission electron microscopy (TEM), which indicated that 
few full-size glycogen particles exist and the average diameter is closer to 25 nm; however, it 
is noted that the sample preparation for TEM may change the apparent size of the particle 
from that in the native state.  
Fig. 2 shows the simulated number of monomer units and of chains as a function of number 
of simulation steps, which is related to actual time. The number of steps will vary 
monotonically with actual time, although the quantitative relation between the two is not 
straightforward. This is because as the number of valid sites for enzyme action changes, a 
step represents decreasing units of time as more and more simultaneous actions become 
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possible. This then changes as hindrance begins limiting access to sites. Therefore the actual 
time varies non-linearly but monotonically with number of steps. 
 
Fig. 2 Variation of simulated number of monomer units (a) and chains (b) with number of 
simulation steps (which varies non-linearly but monotonically with time). 
It is seen that both the number of monomer units and chains initially increase rapidly with 
simulation step and then asymptote to a steady state. From Fig. 2(a), it is apparent that this 
“stoppage” is not representative of an absolute (frozen) end configuration, but that in fact this 
is a dynamic equilibrium. With the number of branches increasing, on the one hand there is 
less and less opportunity for snipped chains to join onto another chain, while on the other 
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hand the glycogen becomes more and more dense, with less space for enzymes. Fig. 2(b) 
shows that the number of chains asymptotes to a constant. The reason for attaining this 
constant, despite the actions of the enzymes still occurring, is that if one chain is branched 
into two chains by GBE, the snipped chain will disappear because it has no place at which it 
can attach, so the number of total chains is unchanged at this asymptotic steady state. The 
reason that the number of monomer units attains a steady state is the competition between 
monomer-unit growth by GS and monomer-unit loss by GBE and GDBE eventually leading 
to a steady state. 
Some models [21, 22, 37, 38] have assumed that glycogen is fractally branched; however, 
there does not seem to be direct evidence for this assumption. Moreover, as noted by Besford 
and co-workers [18], the scattering profile is consistent with random, rather than fractal, 
branching. 
Fig. 3 displays a simulated glycogen 3D conformation when the equilibrium state of growth 
is reached. The periphery (which would be the outer tier in some models) is not crowded, but 
after the steady state is achieved, the total number of chains in this and other regions is 
constant. 
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Fig.  3 A simulated glycogen 3D conformation when the equilibrium state of growth is 
reached. The number of monomer units (denoted by dots) in this particular simulation is 
13,217. 
Fig. 4 shows the pair-distance distribution from our simulations, compared with experimental 
data extracted from the results of Besford et al. [18] in which β particles were obtained by 
gentle acid hydrolysis of α particles. The pair-distance distributions of the simulated particles 
are of similar shape and magnitude as those of the experimentally-analyzed samples. 
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Fig.  4 Comparison between simulated and experimental pair-distance distributions P(r) of 
glycogen β particles. Experimental data, with the different curves being for individual mice, 
extracted from Fig.6 (a) of Besford et al. [18]. The simulated result was averaged over 1635 
simulations of glycogen molecules after reaching a steady state. The quantity r is the distance 
from a shell to the center of mass of a glycogen molecule. 
Fig. 5 compares simulated and experimental [11] CLDs. The experimental data are for human 
liver glycogen; the full data set in Deng et al. [11] shows that the liver-glycogen CLDs from 
different mammals are semiquantitatively similar. The simulated result is averaged over 1635 
individual glycogen molecule simulations. 
Fig. 6 compares simulated and experimental [4] molecular densities of glycogen as function 
of the size of the whole molecule. Here, the size is Rh, the size-exclusion chromatography 
(SEC, a type of gel permeation chromatography, GPC) separation parameter. There is 
evidence [43] that for a complex branched polymer such as glycogen, Rh ≈ Rg (Rg is the radius 
of gyration, which is easily calculated from a simulation), and so we use Rg to replace Rh. The 
latter is a complicated quantity [44, 45]: the corresponding hydrodynamic volume is 
proportional to the weight-average specific viscosity and the number-average molecular 
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weight, which is hard to calculate from a simulation. There is evidence [43] that these two 
quantities do not differ greatly for amylopectin, which like glycogen is a complex highly-
branched glucose polymer. The molecular density is given by ρ(Rh)= 
–
Mw(Rh) / 4/3 π Rh3, 
where 
–
Mw is the weight-average molecular weight. In view of later discussion, note that this 
is the average density over all molecules of that Rh: for all molecules with a given Rh,each 
individual molecule will have a different branching structure, and thus a different 
–
Mwand 
thus a different density. In addition, band broadening is always present to some extent in SEC 
[46]. This is taken into account here with anexponential-Gaussian hybrid (EGH) broadening 
function [47]. The EGH parameters σ was taken as 8.0 nm3 and τ as 0.6 nm3, chosen to best 
match the experimental data. The simulated and experimental results are in satisfactory 
agreement. 
 
 
Fig.  5 Comparison between simulated and experimental [11] CLD of glycogen, normalized 
to have the same maximum. The experimental data are for human liver glycogen. The 
computed results of this Figure and in Fig.  6 agree acceptably after 1635 simulations of 
individual glycogen molecules. 
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Fig.  6 Simulated and experimental [4] molecular density distributions of a size-disperse 
ensemble of glycogen molecules as functions of molecular size Rh. 
The size distribution of (whole, i.e. undebranched) glycogen molecules can be obtained by 
SEC. With differential refractive index detection, this yields the SEC weight distribution 
w(logRh), which is the relative total weight of particles in the size increment d(logRh). Fig. 7 
shows the simulated SEC weight distribution of glycogenβparticles, obtained from the 
average of 1635 individual simulations of glycogen molecules. The curve has a peak around 
27 nm, and this value and the shape are in semi-quantitative agreement with experimental 
SEC data for systems in which the composite glycogen α particles have been broken up into 
their component βparticles by addition of DMSO [5, 6]. In this comparison, SEC band 
broadening was not taken into account; this does not change the qualitative shape of a 
monomodal size distribution such as this, but slightly distorts it. 
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Fig.  7 Simulated SEC weight distribution of glycogen βparticles as a function of radius of 
gyration Rg. 
Given the semi-quantitatively acceptable comparisons given above between simulated and 
experimental results for a wide range of different types of data, it is reasonable to infer that 
useful information for aspects of glycogen structure that are not available experimentally (at 
least at this stage) can be gleaned from the simulation data. However, it must be borne in 
mind that the model used here does not permit the chains to be flexible, which places a 
caveat on the inference. Future work will overcome this limitation. 
The simulations show that the restriction on the size of glycogen molecule is mainly due to 
the activity of GBE and the influence of hindrance (crowding), as evidenced by the 
simulations shown in the Supporting Information, where only GS and GBE are included: 
similar size distributions are seen as those for the more complex mechanisms included in the 
calculation of Fig. 7. It is useful to find out the respective contributions from GBE and 
hindrance for chain-stoppage. Fig.8 gives the average of a large ensemble of simulations for 
molecular density, for frequency of stoppage by GBE, and for frequency of stoppage by 
hindrance as functions of radial distance from the center of mass of the particle. Stoppage 
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from hindrance is calculated by the number of failures of an enzyme action due to crowding, 
and stoppage by GBE is calculated from the number of successful branching events at that 
radius. These will now be discussed one by one. 
 
 
Fig. 8 Density, frequency of chain-stoppage by GBE and frequency of chain-stoppage by 
hindrance as functions of radius (distance from the center of mass) of an ensemble of 
glycogen particles, averaged over those quantities for each individual particle; all in arbitrary 
units. 
Consider first the density (which is that of an individual molecule), which as stated shows a 
maximum very close to the center of mass of the molecule. The small displacement from the 
center is about the size of a monomer unit or one of the biosynthetic enzymes. It was noted 
above that there are contradictory inferences about this density in the literature: the 
simulations of Konkolewicz et al. [26] showed a maximum at the center, while those of 
Melendez and co-workers [13] showed a maximum at the periphery, which was ascribed to 
chain stoppage by crowding. The present simulations qualitatively show the same results as 
those of Konkolewicz et al., the only difference being that our maximum is slightly displaced 
from the center. This difference can be ascribed to the fact that our simulation considers 
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individual monomers and enzymes, rather than adding whole chains as in the work of 
Konkolewicz et al., and the displacement from the center in the present simulations is about 
the sizes of monomer and enzymes. 
Prior to understanding the reason for density decreasing out to the periphery from very close 
to the center in our simulation, we examine the simulated average DP of chains as a function 
of radius, shown in Fig. 9. This was calculated as follows. For each monomer unit in a 
spherical shell, find the total number of monomer units in the chain to which it is attached. 
Then average that over all monomer units attached to a chain in the whole shell. One sees 
that the average DP decreases slightly from the center to ~35 nm, with very few particles 
being larger than this (Fig. 8); above this size, the average DP decreases rapidly, which can 
be ascribed to the ease at which there is space for a snipped chain to be joined to another one. 
The reason for the decrease in density from the maximum in the present simulations and in 
those of Konkolewicz et al.is that most chains are short (as seen in Fig.  5). There is more 
room around the center for small chains rather than long ones, but this restriction diminishes 
as the radius increases. 
The reason for the qualitative difference between the simulated density maximum being at, or 
very close to, the center (the present work and that of Konkolewicz et al.) compared to that of 
Mendelez and related papers (maximum at the periphery) is because the simulations of 
Melendez and co-workers assumed a fractal glycogen growth. In that mode, each chain 
generates two chains. This assumption naturally leads to dense density at the periphery and 
sparse density in the center.  
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Fig.  9 Simulated average DP of chains as a function of radius. The simulated result was 
averaged over 1635 simulations of individual glycogen molecules. The radial increment in 
calculation is 2 nm. 
Next, we turn to the radial dependence of the two different stoppage mechanisms, shown in 
Fig. 8.The maxima in both stoppage by GBE and by hindrance occur at essentially the same 
radius, which is slightly larger than that in density. The simulations in Fig. 8 were stopped 
not long after the steady state was attained; as seen for a simulation carried out for a much 
longer time (Fig. S3 in the SI), the basic effects do not depend on this. The two maxima being 
close to the density maximum is because there is the greatest concentration of monomer units 
for each mechanism to act upon. The distance from the center is commensurate with the size 
of an enzyme. 
Fig. 10 shows the simulated evolution of Nde with simulation step (which it will be recalled 
varies monotonically with time, although it is not proportional to time).There is a significant 
change of the CLD with time until the steady state is achieved. This change is mainly around 
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DP 4, where the initial small peak becomes larger with time. This is attributed to GP, which 
acts on chains with DP ≥ 5 to remove terminal monomer units from the non-reducing ends of 
chains until it reaches a point four residues away. The effect of GP becomes more apparent in 
time because the number of chains of DP > 5 increases, and so the relative number of chains 
with DP 4 increases. As shown in this figure and in Figure 5, there are still many chains 
below 6 (X0 is set as 6), from that in figure which is difference from Fig. S4 in SI. Fig. S4 
shows that when only GS and GBE are included in the simulation, there are no chains below 
DP 6 (which is the lowest value between X0 and Xmin). The differences are attributed to 
actions of the additional enzymes. 
 
 
 
Fig.  10 Simulated CLD as a function of simulation step, normalized at DP 7. Each curve is 
the average of 50 simulations. 
4. Conclusions  
This Monte Carlo approach to simulating the biosynthesis process for glycogen, a complex 
branched glucose polymer, has revealed useful new insights. The model includes all the 
enzymes thought to give rise to the branching structure of glycogen: GS, GBE, GP, GDBE 
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and GAA, and takes account of the activities and mode of action of these enzymes. The 
model is applicable to glycogen β particles, which are the smaller entities visible in electron 
micrographs of this molecule, and which can be bound together into larger α particles, with 
the β particles still distinct in the aggregation. The simulated chain-length, total size, pair-
distance and radial density distributions are all in semi-quantitative agreement with the 
limited available data. 
The simulations also suggest effects which have not yet been observed experimentally, the 
explanations for which have been given above. The numbers of chains and of monomer units 
increase with time and asymptote to a steady state; this could be observed, for example, by 
studying this time evolution in isolated liver cells. The radial density is at a maximum close 
to the center; this could be observed experimentally by SAXS or SANS studies of samples 
with very narrow size distributions, as could be done using these scattering techniques on 
samples eluted from SEC. This result is in accord with the simulations of Konkolewicz et al., 
but is qualitatively different to the maximum being at the periphery seen in the pioneering but 
less realistic simulations of Mendelez and co-workers [13]; currently, however, this latter 
inference (which the present work suggests is incorrect) is often assumed in the literature. It 
is noted that a periphery maximum is indeed seen in synthetic dendritic polymers [14], but in 
these, polymer growth is very regular and involves a single mechanism, unlike the random 
growth with two main mechanisms involving chain-length specificity that is applicable to 
glycogen. It is noted that the inference that the density maximum is near the center makes it 
unlikely that the “crowding-budding” mechanism [48] for the formation of α particles could 
be valid. 
One application of the increased understanding gained from the present simulations is in 
diabetes. As discussed in the Introduction, liver-glycogen β particles (which are the subject of 
this paper) can become bound together to make larger composite α particles, but this binding 
is compromised in diabetes. Recent data from our laboratory [4] suggests that the molecular 
structure of healthy and diabetic β particles are different, and so understanding this is an area 
of interest for diabetes management. 
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